Design of Cell-Permeable Inhibitors of Eukaryotic Translation Initiation Factor 4E (eIF4E) for Inhibiting Aberrant Cap-Dependent Translation in Cancer
E. L. Cardenas, R. L. O'Rourke, A. Menon, J. Meagher, J. Stuckey, A. L. Garner
This study designs cell-permeable inhibitors of eIF4E to block cap-dependent translation in cancer by using an acyclic nucleoside phosphonate prodrug strategy.
bioRxiv · May 23, 2023Cancer Biology